Biotechnology IPO 2026: Lycia Eyes $265M, Faces Big Risks
Biotechnology IPO 2026: Lycia Therapeutics eyes up to $264.6M. What the money funds, the runway and the risks in the filing.
Biotechnology IPO 2026: Lycia Therapeutics eyes up to $264.6M. What the money funds, the runway and the risks in the filing.